Analyst Thomas Smith of Leerink Partners reiterated a Buy rating on MoonLake Immunotherapeutics (MLTX – Research Report), retaining the ...

EQS-News: APONTIS PHARMA AG / Key word (s): 9 Month figures/Change in Forecast APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

The Global Topical Drug Delivery Market Size is projected to grow at a CAGR of 6.3% from 2024 to 2031, according to a new report published by Verified Market Research ®. The report reveals that the ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

DelveInsight's Respiratory Disease Testing Market Insights report provides the current and forecast market analysis, individual ...